Table 1 Clinicopathologic characteristics of the patients in the two groups
ENDO | OPEN | P | |
|---|---|---|---|
Characteristics | |||
Sex (male:female) | 0:37 | 3:38 | 0.799 |
Age (years) | 42.3 ± 7.6 | 49.0 ± 10.8 | 0.003 |
Tumor size (cm) | 0.5 ± 0.231 | 0.41 ± 0.264 | 0.116 |
Capsule invasion (+/total) | 3/37 | 4/41 | 0.799 |
Extrathyroid (+/total) | 1/37 | 2/41 | 0.618 |
Multiplicity (+/total) | 3/37 | 5/41 | 0.552 |
LN meta (+/total) | 5/37 | 1/41 | 0.037 |
Stage | 0.561 | ||
I/II/III/IV | 34/0/3/0 | 39/0/2/0 | |
Number of retrieved lymph nodes | 3.63 ± 2.1 | 3.82 ± 3.28 | 0.78 |
OP time (min) | 138.4 ± 36.9 | 112.3 ± 14 | <0.01 |
Hospital stay (days) | 3.35 ± 094 | 3.17 ± 1.16 | 0.457 |
Complications | 1 | 1 | 0.941 |
Bleeding | 5 | 2 | |
Transient vocal cord palsy | |||
Paresthesia | |||
Postoperative pain | |||
VAS 1 | 4.7 ± 1.7 | 3.8 ± 1.9 | 0.037 |
VAS 7 | 2.6 ± 1.9 | 1.7 ± 1.8 | 0.026 |
Number of patients with neck discomfort | |||
POD 1 month | 6 | 5 | 0.748 |
POD 3 months | 3 | 2 | 0.664 |
Cosmesis | 1.43 ± 0.55 | 3.21 ± 0.72 | <0.001 |
Recurrence | 1 | 1 | 0.667 |
Follow-up period (months) | 54.3 ± 21.7 | 47.4 ± 13.6 | 0.1 |